295 related articles for article (PubMed ID: 7679407)
1. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously.
Kupfer SR; Underwood LE; Baxter RC; Clemmons DR
J Clin Invest; 1993 Feb; 91(2):391-6. PubMed ID: 7679407
[TBL] [Abstract][Full Text] [Related]
2. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans.
Clemmons DR; Smith-Banks A; Underwood LE
J Clin Endocrinol Metab; 1992 Jul; 75(1):234-8. PubMed ID: 1619015
[TBL] [Abstract][Full Text] [Related]
3. Effects of growth hormone and insulin-like growth factor-I singly and in combination on in vivo capacity of urea synthesis, gene expression of urea cycle enzymes, and organ nitrogen contents in rats.
Grøfte T; Wolthers T; Jensen SA; Møller N; Jørgensen JO; Tygstrup N; Orskov H; Vilstrup H
Hepatology; 1997 Apr; 25(4):964-9. PubMed ID: 9096605
[TBL] [Abstract][Full Text] [Related]
4. Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome.
Lieberman SA; Butterfield GE; Harrison D; Hoffman AR
J Clin Endocrinol Metab; 1994 Feb; 78(2):404-10. PubMed ID: 7508949
[TBL] [Abstract][Full Text] [Related]
5. Use of growth hormone and insulin-like growth factor I in catabolism that is induced by negative energy balance.
Clemmons DR
Horm Res; 1993; 40(1-3):62-7. PubMed ID: 8300052
[TBL] [Abstract][Full Text] [Related]
6. MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism.
Murphy MG; Plunkett LM; Gertz BJ; He W; Wittreich J; Polvino WM; Clemmons DR
J Clin Endocrinol Metab; 1998 Feb; 83(2):320-5. PubMed ID: 9467534
[TBL] [Abstract][Full Text] [Related]
7. Dietary carbohydrate content determines responsiveness to growth hormone in energy-restricted humans.
Snyder DK; Clemmons DR; Underwood LE
J Clin Endocrinol Metab; 1989 Oct; 69(4):745-52. PubMed ID: 2778033
[TBL] [Abstract][Full Text] [Related]
8. Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults.
Young SC; Underwood LE; Celniker A; Clemmons DR
J Clin Endocrinol Metab; 1992 Aug; 75(2):603-8. PubMed ID: 1379258
[TBL] [Abstract][Full Text] [Related]
9. Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis, and body composition.
Snyder DK; Clemmons DR; Underwood LE
J Clin Endocrinol Metab; 1988 Jul; 67(1):54-61. PubMed ID: 3379136
[TBL] [Abstract][Full Text] [Related]
10. Anabolic effects of growth hormone in obese diet-restricted subjects are dose dependent.
Snyder DK; Underwood LE; Clemmons DR
Am J Clin Nutr; 1990 Sep; 52(3):431-7. PubMed ID: 2203249
[TBL] [Abstract][Full Text] [Related]
11. Combined recombinant human growth hormone and recombinant human insulin-like growth factor I: lack of synergy on whole body protein anabolism in normally fed subjects.
Mauras N
J Clin Endocrinol Metab; 1995 Sep; 80(9):2633-7. PubMed ID: 7673406
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I but not growth hormone attenuates dexamethasone-induced catabolism in parenterally fed rats.
Lo HC; Hinton PS; Yang H; Unterman TG; Ney DM
JPEN J Parenter Enteral Nutr; 1996; 20(3):171-7. PubMed ID: 8776688
[TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of recombinant human insulin-like growth factor-I in humans: comparison with recombinant human growth hormone.
Mauras N; Haymond MW
Pediatr Nephrol; 1996 Jun; 10(3):318-23. PubMed ID: 8792396
[TBL] [Abstract][Full Text] [Related]
14. Differential long-term effects of insulin-like growth factor-I (IGF-I) growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats.
Fielder PJ; Mortensen DL; Mallet P; Carlsson B; Baxter RC; Clark RG
Endocrinology; 1996 May; 137(5):1913-20. PubMed ID: 8612531
[TBL] [Abstract][Full Text] [Related]
15. Effects of continuous infusion of insulin-like growth factor I and II, alone and in combination with thyroxine or growth hormone, on the neonatal hypophysectomized rat.
Glasscock GF; Hein AN; Miller JA; Hintz RL; Rosenfeld RG
Endocrinology; 1992 Jan; 130(1):203-10. PubMed ID: 1370151
[TBL] [Abstract][Full Text] [Related]
16. Organ-specific effects and interactions of acute insulin-like growth factor I (IGF-I) and growth hormone (GH).
Pascual M; Larralde J; Martínez JA
Growth Dev Aging; 1995; 59(4):181-91. PubMed ID: 8770610
[TBL] [Abstract][Full Text] [Related]
17. Effects of insulin-like growth factor-I and growth hormone in models of parenteral nutrition.
Ney DM
JPEN J Parenter Enteral Nutr; 1999; 23(6 Suppl):S184-9. PubMed ID: 10571453
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor 1 has beneficial effects, whereas growth hormone has limited effects on postoperative protein metabolism, gut integrity, and splenic weight in rats with chronic mild liver injury.
Inaba T; Saito H; Fukushima R; Hashiguchi Y; Lin MT; Inoue T; Fukatsu K; Muto T; Oka T; Takenaka A; Takahashi S; Noguchi T
JPEN J Parenter Enteral Nutr; 1997; 21(2):55-62. PubMed ID: 9084006
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver.
Maiter D; Walker JL; Adam E; Moatsstaats B; Mulumba N; Ketelslegers JM; Underwood LE
Endocrinology; 1992 Jun; 130(6):3257-64. PubMed ID: 1375898
[TBL] [Abstract][Full Text] [Related]
20. The effects of subcutaneous insulin-like growth factor-I infusion in insulin-dependent diabetes mellitus.
Bach MA; Chin E; Bondy CA
J Clin Endocrinol Metab; 1994 Oct; 79(4):1040-5. PubMed ID: 7525624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
